Literature DB >> 32298486

Plasmacytoid lymphocytes in SARS-CoV-2 infection (Covid-19).

David Foldes1, Richard Hinton1, Siamak Arami1, Barbara J Bain2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32298486      PMCID: PMC7262137          DOI: 10.1002/ajh.25834

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


× No keyword cloud information.
A 59‐year‐old man with no known past medical history presented to the emergency department with dyspnea, abdominal pain and malaise. Clinical assessment revealed hypoxia with bibasal crepitations on chest auscultation. A chest radiograph showed extensive bilateral air space opacification involving all zones. He was hospitalized with suspicion of infection with the novel coronavirus, SARS‐CoV‐2, later proven by positive RT‐PCR. Blood tests showed multi‐organ failure with deranged liver function tests (alkaline phosphatase 611 IU/L, alanine aminotransferase 208 IU/L, gamma‐glutamyl transferase 435 IU/L), acute kidney injury (serum creatinine 197 μmol/L), and raised inflammatory markers (C‐reactive protein 137 mg/L, ferritin 3303 μg/L). His blood count showed a hemoglobin concentration of 109 g/L, platelet count of 921 × 109/L and total white cell count of 9.8 × 109/L with a neutrophil count of 8.5 × 109/L, and a lymphopenia of 0.9 × 109/L. His blood film showed atypical lymphocytes that appeared reactive. Prominent among these were lymphoplasmacytoid lymphocytes with an eccentric nucleus, deeply basophilic cytoplasm and a prominent paranuclear hof (top and bottom left, ×100 objective). Lymphocytes with prominent cytoplasmic inclusions (Mott cells) were also seen (bottom right). The patient was treated with supplementary high‐flow oxygen, intravenous antibiotics and intravenous fluids. He recovered and became oxygen‐independent on day 9 post‐admission, and was discharged on day 10. The newly emerged pandemic caused by this novel coronavirus presents a challenge to health services across the world. In studies reported from China, lymphopenia was observed in 72 and 85% of patients1, 2 with reduced numbers of T cells (CD4‐positive and CD8‐positive), B cells and natural killer (NK) cells. A favorable clinical course correlated with an increasing lymphocyte count and improvements in B cell numbers and CD8‐positive T cell numbers; multivariate analysis showed an adverse significance of reduced B cells, reduced CD8‐positive T cells and an increased CD4/CD8 ratio during the course of the illness. Northwick Park Hospital has so far admitted more than 300 patients with Covid‐19. In our experience, the lymphocyte features illustrated above are common in blood films of patients presenting to hospital with clinically significant Covid‐19. The observation of plasmacytoid lymphocytes supports a provisional clinical diagnosis of this condition.

CONFLICT OF INTERESTS

The authors state there are no conflicts of interest.
  3 in total

1.  Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study.

Authors:  Xiaobo Yang; Yuan Yu; Jiqian Xu; Huaqing Shu; Jia'an Xia; Hong Liu; Yongran Wu; Lu Zhang; Zhui Yu; Minghao Fang; Ting Yu; Yaxin Wang; Shangwen Pan; Xiaojing Zou; Shiying Yuan; You Shang
Journal:  Lancet Respir Med       Date:  2020-02-24       Impact factor: 30.700

2.  Characteristics of Peripheral Lymphocyte Subset Alteration in COVID-19 Pneumonia.

Authors:  Fan Wang; Jiayan Nie; Haizhou Wang; Qiu Zhao; Yong Xiong; Liping Deng; Shihui Song; Zhiyong Ma; Pingzheng Mo; Yongxi Zhang
Journal:  J Infect Dis       Date:  2020-05-11       Impact factor: 5.226

3.  Plasmacytoid lymphocytes in SARS-CoV-2 infection (Covid-19).

Authors:  David Foldes; Richard Hinton; Siamak Arami; Barbara J Bain
Journal:  Am J Hematol       Date:  2020-04-28       Impact factor: 10.047

  3 in total
  14 in total

1.  Overview of the Haematological Effects of COVID-19 Infection.

Authors:  T M Wiggill; E S Mayne; J L Vaughan; S Louw
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  The Novel Coronavirus and Inflammation.

Authors:  J A George; E S Mayne
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

3.  Laboratory divergences in concurrent diagnosis of acute myeloid leukemia relapse and COVID-19: A case report.

Authors:  Adrien Nizet; Jacques Foguenne; André Gothot; Françoise Tassin; Aurore Keutgens
Journal:  Int J Lab Hematol       Date:  2021-04-21       Impact factor: 3.450

4.  Atypical lymphocyte morphology in SARS-CoV-2 infection.

Authors:  Siraj M El Jamal; Christian Salib; Aryeh Stock; Norlita I Uriarte-Haparnas; Benjamin S Glicksberg; Julie Teruya-Feldstein; Francine R Dembitzer; Girish N Nadkarni; Adolfo Firpo-Betancourt
Journal:  Pathol Res Pract       Date:  2020-06-10       Impact factor: 3.250

Review 5.  The clinical impact of COVID-19 epidemic in the hematologic setting.

Authors:  Carlo Finelli; Sarah Parisi
Journal:  Adv Biol Regul       Date:  2020-07-16

Review 6.  Haematological manifestations of COVID-19: From cytopenia to coagulopathy.

Authors:  Charles Agbuduwe; Supratik Basu
Journal:  Eur J Haematol       Date:  2020-08-31       Impact factor: 3.674

7.  Plasmacytoid lymphocytes in SARS-CoV-2 infection (Covid-19).

Authors:  David Foldes; Richard Hinton; Siamak Arami; Barbara J Bain
Journal:  Am J Hematol       Date:  2020-04-28       Impact factor: 10.047

Review 8.  SARS-CoV-2 Infected Patient: from a Hematologist's Perspective.

Authors:  Firas Kreidieh; Sally Temraz
Journal:  Mediterr J Hematol Infect Dis       Date:  2020-11-01       Impact factor: 2.576

9.  Rapid screening of COVID-19 patients using white blood cell scattergrams, a study on 381 patients.

Authors:  Jennifer Osman; Jérome Lambert; Marie Templé; Floriane Devaux; Rémy Favre; Claire Flaujac; Delphine Bridoux; Stéphanie Marque-Juillet; Fabrice Bruneel; François Mignon; Ernesto Diaz-Flores; Véronique Hentgen; Alix Greder-Belan; Reza Azarian; Mehrsa Koukabi; Philippe Rousselot; Victoria Raggueneau; Benjamin Manéglier
Journal:  Br J Haematol       Date:  2020-07-05       Impact factor: 8.615

10.  Peripheral Blood Smear Demonstration of Lymphocyte Changes in Severe COVID-19.

Authors:  Chun-Tsu Lee; Winnie Z Y Teo
Journal:  Am J Trop Med Hyg       Date:  2020-10       Impact factor: 3.707

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.